Author:
Siena Salvatore,Secondino Simona,Giannetta Laura,Carminati Ornella,Pedrazzoli Paolo
Reference47 articles.
1. Bal DG, Nixon DW, Foerster SB, Brownson RC, et al. American Cancer Society textbook of clinical oncology. 2nd ed. 1995. p. 40–63.
2. Filgrastim (r-metHuG-CSF): the first 10 years;Welte;Blood,1996
3. A new form of filgrastim with sustained duration in vivo and enhanced ability to mobilise PBPC in both mice and human;Molineux;Exp. Hematol.,1999
4. Filgrastim-SD, a sustained duration form of filgrastim (rhuG-CSF) has similar effects on neutrophil function compared to filgrastim;McKenna;Blood,1998
5. Crawford J, Garst J, Lee M. A phase II multicycle trial of pegfilgrastim compared to filgrastim after myelosuppressive chemotherapy. Presented at the 9th World Conference on Lung Cancer, International Association for the Study of Lung Cancer, Tokyo, Japan, September 2000 [abstract 922].
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献